Home > Food & Beverages > Nutraceuticals > Omega 3 > Glutathione Market

Glutathione Market Share

Report ID: GMI4147
Published Date: Dec 2024
Report Format: PDF

Download Free Sample

Glutathione Market Share

The competitive landscape of the glutathione industry features several key players, each with distinct strengths. Anhui GSH Bio-Technology specializes in the production of high-quality glutathione, with a strong focus on the pharmaceutical and cosmetic sectors. Cayman Chemical Company is recognized for its extensive research and high-grade glutathione products, primarily catering to the scientific and clinical markets. Haihang Industry offers a broad portfolio of glutathione-based supplements and is well-positioned in both domestic and international markets.

Herbo Nutra focuses on the natural and herbal supplements market, providing glutathione products with an emphasis on plant-based ingredients. Kaiping Genuine Biochemical Pharmaceutical targets the pharmaceutical industry, particularly for liver health treatments, through its specialized glutathione formulations. KOHJIN Life Sciences leads with advanced production techniques, focusing on premium-quality glutathione for skin-care products. Kyowa Hakko Bio is a significant player known for its biotechnology-driven innovation, offering high-purity glutathione for health applications. Meteoric Biopharmaceuticals is expanding its presence in the biopharmaceutical and supplement sectors, with a focus on health solutions.

Glutathione Market Companies

Major players operating in the glutathione industry are:

Anhui GSH Bio-Technology
Cayman Chemical Company
Haihang Industry
Herbo Nutra
Kaiping Genuine Biochemical Pharmaceutical
KOHJIN Life Sciences
Kyowa Hakko Bio
Meteoric Biopharmaceuticals
Shandong Jincheng Biological Pharmaceutical
Xi’an Fengzu Biological Technology
YAOPHARMA

Authors: Kiran Pulidindi, Keshav Tandle

Frequently Asked Questions (FAQ) :

The market size of glutathione reached USD 252.9 million in 2024 and is estimated to grow at a 6.8% CAGR from 2025 to 2034, driven by its antioxidant properties and health benefits.

The glutathione reduced segment held over USD 162.1 million in 2024 and is anticipated to expand at a 6.7% CAGR from 2025 to 2034, owing to its superior bioavailability and effectiveness in various health applications.

The U.S. market was valued at over USD 71.2 million in 2024 and is expected to witness a 7.1% CAGR through 2034, led by high demand in the pharmaceutical, dietary supplement, and cosmetic industries.

The key players in the industry include Anhui GSH Bio-Technology, Cayman Chemical Company, Haihang Industry, Herbo Nutra, Kaiping Genuine Biochemical Pharmaceutical, KOHJIN Life Sciences, Kyowa Hakko Bio, Meteoric Biopharmaceuticals, Shandong Jincheng Biological Pharmaceutical, Xian Fengzu Biological Technology, and YAOPHARMA.